You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 222 No. 12, December 18, 1972 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Radioimmunoassay Detection of Hepatitis Type B Antigen

A Prospective Study in Blood Donors and Recipients

Gino L. Giorgini, Jr., MD; F. Blaine Hollinger, MD; Leslie Leduc; S. Issarescu, MD; Jack George, MT; Alden Blackman, MD; Walter R. Thayer, Jr., MD

JAMA. 1972;222(12):1514-1518.


Abstract

Of 161 recipients who received blood transfusions at the Providence, RI, Veteran's Administration Hospital, seven (4.3%) developed biochemical and/or histological evidence of viral hepatitis. Hepatitis type B antigen (HBAg) appeared in the sera from five of these patients during the course of their disease. One of these patients had received a unit of blood containing HBAg detected by counterimmunoelectrophoresis (CIE). The other four patients with HBAg-positive serum had received blood presumably negative for HBAg by CIE. However, subsequent studies using a sensitive double-antibody radioimmunoassay (RIA-DA) procedure revealed HBAg in ten of the 91 units administered to these four patients in which type B viral hepatitis had developed. Thus, donor blood negative for HBAg by the currently recommended CIE method may contain low HBAg concentrations detectable by RIA-DA which, when administered to recipients, can result in viral hepatitis type B.



Author Affiliations

From the Department of Pathology, Providence Veterans Administration Hospital (Drs. Issarescu and Thayer and Mr. George), the Department of Medical Research, Rhode Island Hospital (Drs. Giorgini and Blackman and Ms. Leduc), the Department of Medical Science, Brown University (Drs. Giorgini and Thayer), Providence, RI, and the Department of Virology and Epidemiology, Baylor College of Medicine, Houston (Dr. Hollinger). Dr. Giorgini is now with the Gastroenterology Clinic and Research Branch, Naval Hospital, National Naval Medical Center, Bethesda, Md.


Footnotes

Reprint requests to Department of Virology and Epidemiology, Baylor College of Medicine, Houston 77025 (Dr. Hollinger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Post-transfusion Hepatitis: Current Perspectives
AACH and KAHN
ANN INTERN MED 1980;92:539-546.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.